BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29974981)

  • 1. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
    Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
    NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved repeatability of dynamic contrast-enhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients.
    Klawer EME; van Houdt PJ; Simonis FFJ; van den Berg CAT; Pos FJ; Heijmink SWTPJ; Isebaert S; Haustermans K; van der Heide UA
    Magn Reson Med; 2019 May; 81(5):3358-3369. PubMed ID: 30656738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
    Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability of arterial input functions and kinetic parameters in muscle obtained by dynamic contrast enhanced MR imaging of the head and neck.
    Koopman T; Martens RM; Lavini C; Yaqub M; Castelijns JA; Boellaard R; Marcus JT
    Magn Reson Imaging; 2020 May; 68():1-8. PubMed ID: 31978517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CT.
    Korporaal JG; van den Berg CA; van Osch MJ; Groenendaal G; van Vulpen M; van der Heide UA
    Magn Reson Med; 2011 Nov; 66(5):1267-74. PubMed ID: 21604291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
    Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
    Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
    Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
    NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis of prostate cancer using independent component analysis.
    Mehrabian H; Da Rosa M; Haider MA; Martel AL
    Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.
    Peled S; Vangel M; Kikinis R; Tempany CM; Fennessy FM; Fedorov A
    Acad Radiol; 2019 Sep; 26(9):e241-e251. PubMed ID: 30467073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
    Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
    J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different population-averaged arterial-input-functions in dynamic contrast-enhanced MRI of the prostate: Effects on pharmacokinetic parameters and their diagnostic performance.
    Othman AE; Falkner F; Kessler DE; Martirosian P; Weiss J; Kruck S; Kaufmann S; Grimm R; Kramer U; Nikolaou K; Notohamiprodjo M
    Magn Reson Imaging; 2016 May; 34(4):496-501. PubMed ID: 26708031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
    Fan X; Chatterjee A; Pittman JM; Yousuf A; Antic T; Karczmar GS; Oto A
    Acad Radiol; 2022 Jun; 29(6):796-803. PubMed ID: 34583866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCE-MRI protocol for constraining absolute pharmacokinetic modeling errors within specific accuracy limits.
    Knight SP; Meaney JF; Fagan AJ
    Med Phys; 2019 Aug; 46(8):3592-3602. PubMed ID: 31148187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operator dependency of arterial input function in dynamic contrast-enhanced MRI.
    Kleppestø M; Bjørnerud A; Groote IR; Kim M; Vardal J; Larsson C
    MAGMA; 2022 Feb; 35(1):105-112. PubMed ID: 34213687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.